SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. (Q34547626)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
scientific article

    Statements

    SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit